A gut toxin that’s been linked to colorectal cancers for more than two decades may be to the sharp rise of the disease in ...

Cancer patients invariably develop resistance to targeted drugs, so drugmakers develop strategies to combat it before ...

Cancer patients invariably develop resistance to targeted drugs, so drugmakers develop strategies to combat it before ...

Newer-generation Bruton's tyrosine kinase (BTK) inhibitors have found a place in the management of follicular lymphoma, a ...

The first patient with relapsed or refractory CD5-positive T-cell lymphoma has been dosed with the CAR-T cell therapy MB-105.

Another study found that people who had high levels of vitamin D in their diet had a 25% lower risk of developing colorectal ...

Novel CAR design selectively targets malignant cells for patients with relapsed/refractory CD5-positive hematological diseasesHOUSTON, April 22, ...

Monitoring and analyzing gut microbes may help predict how myeloma patients will respond to CAR T-cell therapy, research ...

As research unfolds, the San Antonio Fire Department has tried to stay ahead of the curve with new and evolving protocols.

Multiple hospitals in the Texas Medical Center suffered power outages Monday afternoon. A Houston Methodist spokesperson ...

Compass Therapeutics (CMPX) announced the first patient has been dosed in an Investigator Sponsored Trial, IST, to evaluate tovecimig for the ...